Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats

Neuroscience

Volumn 238, Issue , 2013, Pages 209-217

  Zhang, D ^a   Hu, Y ^a   Sun, Q ^a   Zhao, J ^a   Cong, Z ^a   Liu, H ^c   Zhou, M ^a   Li, K ^b   Hang, C ^a,c  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

5Z 7 oxozeaenol; AP 1; Inflammation; NF B; TAK1; Traumatic brain injury

Indexed keywords

7 OXOZEAENOL; NEUROPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN INJURIES; CEREBRAL CORTEX; MALE; MAP KINASE KINASE KINASES; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; ZEARALENONE;

EID: 84875612367     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.02.022     Document Type: Article

References (44)

1. Beni S.M., Kohen R., Reiter R.J., Tan D.X., Shohami E. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2004, 18:149-151.
2. Bersudsky Y., Patishi Y., Bitsch Jensen J., Mork A., Kofman O., Belmaker R.H. The effect of acute and chronic lithium on forskolin-induced reduction of rat activity. J Neural Transm 1997, 104:943-952.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
4. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett 2007, 425:177.
5. Chen X.R., Besson V.C., Palmier B., Garcia Y., Plotkine M., Marchand-Leroux C. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J Neurotrauma 2007, 24:1119-1131.
6. Chen G., Shi J., Jin W., Wang L., Xie W., Sun J., Hang C. Progesterone administration modulates TLRS/NF-κB signaling pathway in rat brain after cortical contusion. Ann Clin Lab Sci 2008, 38:65-74.
7. Chen S.F., Hsu C.W., Huang W.H., Wang J.Y. Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br J Pharmacol 2008, 155:1279-1296.
8. Chen G., Zhang S., Shi J., Ai J., Qi M., Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 2009, 216:398-406.
9. Dai W.J., Funk A., Herdegen T., Unger T., Culman J. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 1999, 30:2391-2398.
10. Dey N., Liu T., Garofalo R.P., Casola A. TAK1 regulates NF-κB and AP-1 activation in airway epithelial cells following RSV infection. Virology 2011, 418:93-101.
11. Hailer N.P., Vogt C., Korf H.W., Dehghani F. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci 2005, 21:2347-2360.
12. Hang C.H., Shi J.X., Tian J., Li J.S., Wu W., Yin H.X. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res 2004, 1026:23-32.
13. Hang C.H., Shi J.X., Li J.S., Wu W., Yin H.X. Concomitant upregulation of nuclear factor-kB activity, proinflammatory cytokines and ICAM-1 in the injured brain after cortical contusion trauma in a rat model. Neurol India 2005, 53:312-317.
14. Hayes R.L., Yang K., Raghupathi R., McIntosh T.K. Changes in gene expression following traumatic brain injury in the rat. J Neurotrauma 1995, 12:779-790.
15. Hou D.X., Luo D., Tanigawa S., Hashimoto F., Uto T., Masuzaki S., Fujii M., Sakata Y. Prodelphinidin B-4 3'-O-gallate, a tea polyphenol, is involved in the inhibition of COX-2 and iNOS via the downregulation of TAK1-NF-kappaB pathway. Biochem Pharmacol 2007, 74:742-751.
16. Kajino-Sakamoto R., Inagaki M., Lippert E., Akira S., Robine S., Matsumoto K., Jobin C., Ninomiya-Tsuji J. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol 2008, 181:1143.
17. Lee A.K., Sung S.H., Kim Y.C., Kim S.G. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation. Br J Pharmacol 2003, 139:11-20.
18. Li G.Z., Zhang Y., Zhao J.B., Wu G.J., Su X.F., Hang C.H. Expression of myeloid differentiation primary response protein 88 (Myd88) in the cerebral cortex after experimental traumatic brain injury in rats. Brain Res 2011, 1396:96-104.
19. Lloyd E., Somera-Molina K., Van Eldik L.J., Watterson D.M., Wainwright M.S. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflamm 2008, 5:28.
20. Ma F.Y., Tesch G.H., Ozols E., Xie M., Schneider M.D., Nikolic-Paterson D.J. TGF-beta1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Am J Physiol Renal Physiol 2011, 300:F1410-1421.
21. Maas A.I., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 2008, 7:728-741.
22. McIntosh T.K., Saatman K.E., Raghupathi R., Graham D.I., Smith D.H., Lee V.M., Trojanowski J.Q. The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropath Appl Neuro 1998, 24:251-267.
23. Morganti-Kossmann M.C., Satgunaseelan L., Bye N., Kossmann T. Modulation of immune response by head injury. Injury 2007, 38:1392-1400.
24. Muller J.M., Rupec R.A., Baeuerle P.A. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 1997, 11:301-312.
25. Neubert M., Ridder D.A., Bargiotas P., Akira S., Schwaninger M. Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ 2011, 18:1521-1530.
26. Nijboer C.H., Heijnen C.J., Groenendaal F., van Bel F., Kavelaars A. Alternate pathways preserve tumor necrosis factor-alpha production after nuclear factor-kappaB inhibition in neonatal cerebral hypoxia-ischemia. Stroke 2009, 40:3362-3368.
27. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999, 398:252-256.
28. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999, 398:252-255.
29. Ninomiya-Tsuji J., Kajino T., Ono K., Ohtomo T., Matsumoto M., Shiina M., Mihara M., Tsuchiya M., Matsumoto K. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 2003, 278:18485-18490.
30. Omori E., Matsumoto K., Sanjo H., Sato S., Akira S., Smart R.C., Ninomiya-Tsuji J. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem 2006, 281:19610-19617.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press.
32. Safina A., Ren M., Vandette E., Bakin A. TAK1 is required for TGF-β1-mediated regulation of matrix metalloproteinase-9 and metastasis. Oncogene 2007, 27:1198-1207.
33. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005, 6:1087-1095.
34. Serkkola E., Hurme M. Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-1β gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur J Biochem 2005, 213:243-249.
35. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., Lee K.Y., Bussey C., Steckel M., Tanaka N. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Gene Dev 2005, 19:2668-2681.
36. Shojo H., Kaneko Y., Mabuchi T., Kibayashi K., Adachi N., Borlongan C.V. Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience 2010, 171:1273-1282.
37. Su XF, Wang HD, Zhao JB, Pan H, Mao L (2011) Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-kappa B pathway after traumatic brain injury in the rat. Mediators Inflamm 2011:807142.
38. Takaesu G., Surabhi R.M., Park K.J., Ninomiya-Tsuji J., Matsumoto K., Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 2003, 326:105-115.
39. Wang J.W., Wang H.D., Zhong W.Z., Li N., Cong Z.X. Expression and cell distribution of metabotropic glutamate receptor 5 in the rat cortex following traumatic brain injury. Brain Res 2012, 1464:73-81.
40. White B.J., Tarabishy S., Venna V.R., Manwani B., Benashski S., McCullough L.D., Li J. Protection from cerebral ischemia by inhibition of TGFbeta-activated kinase. Exp Neurol 2012, 237:238-245.
41. Xu J., Kim G.M., Ahmed S.H., Xu J.M., Yan P., Xu X.M., Hsu C.Y. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 2001, 21:92-97.
42. Zhuang Z., Zhou M.L., You W.C., Zhu L., Ma C.Y., Sun X.J., Shi J.X. Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci 2012, 13:47.
43. Zweckberger K., Stoffel M., Baethmann A., Plesnila N. Effect of decompression craniotomy on increase of contusion volume and functional outcome after controlled cortical impact in mice. J Neurotrauma 2003, 20:1307-1314.
44. Zweckberger K., Eros C., Zimmermann R., Kim S.W., Engel D., Plesnila N. Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J Neurotrauma 2006, 23:1083-1093.